Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Relay Therapeutics, Inc. | RLAY | 14.11M | $263.93M |
Solid Biosciences Inc. | SLDB | 11.91M | $118.95M |
MeiraGTx Holdings plc | MGTX | 10.79M | $145.73M |
BioCryst Pharmaceuticals, Inc. | BCRX | 10.31M | $103.09M |
Amylyx Pharmaceuticals, Inc. | AMLX | 8.33M | $149.69M |
Kardigan, Inc. | KARD | 8.2M | $195.59M |
Roivant Sciences Ltd. | ROIV | 8.09M | $286.14M |
Edgewise Therapeutics, Inc. | EWTX | 4.37M | $177.71M |
Nurix Therapeutics, Inc. | NRIX | 4.32M | $104.81M |
Spyre Therapeutics, Inc. | SYRE | 4.32M | $383.48M |
Zymeworks Inc. | ZYME | 4.18M | $109.34M |
Travere Therapeutics, Inc. | TVTX | 3.75M | $213.18M |
Tango Therapeutics, Inc. | TNGX | 3.38M | $105.57M |
Celcuity Inc. | CELC | 3.2M | $334.49M |
Dyne Therapeutics, Inc. | DYN | 2.69M | $59.73M |
Avalyn Pharma Inc. Common Stock | AVLN | 2.68M | $88.07M |
Corvus Pharmaceuticals, Inc. | CRVS | 2.67M | $39.85M |
Rhythm Pharmaceuticals, Inc. | RYTM | 2.59M | $287.16M |
Evolus, Inc. | EOLS | 2.46M | $17.07M |
Praxis Precision Medicines, Inc. | PRAX | 2.04M | $681.63M |